UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Molecular abnormalities in lung cancer

Journal of clinical oncology, 1998-03, Vol.16 (3), p.1207-1217

1998

Volltextzugriff (PDF)

Use of cytokeratins 7 and 20 in determining the origin of metastatic carcinoma of unknown primary, with special emphasis on lung cancer

European journal of cancer prevention, 2001-02, Vol.10 (1), p.77-82

2001

Volltextzugriff (PDF)

Randomized trial of chemotherapy and radiation therapy with or without warfarin for limited-stage small-cell lung cancer: a Cancer and Leukemia Group B study

Journal of clinical oncology, 1997-11, Vol.15 (11), p.3378-3387

1997

Volltextzugriff (PDF)

Role of serum tumor markers CA 125 and CEA in non-small cell lung cancer

Anticancer research, 2001-03, Vol.21 (2B), p.1241

2001

Volltextzugriff (PDF)

Non-Hodgkin's lymphomas: current classification and management

CA: a cancer journal for clinicians, 1997-11, Vol.47 (6), p.351-372

1997

Volltextzugriff (PDF)

Molecular and pathologic markers in stage I non-small-cell carcinoma of the lung

Journal of clinical oncology, 1995-05, Vol.13 (5), p.1265-1279

1995

Volltextzugriff (PDF)

Dose-Intensive Therapy for Limited-Stage Small-Cell Lung Cancer: Long-Term Outcome

Journal of clinical oncology, 1999-04, Vol.17 (4), p.1175-1184

1999

Volltextzugriff (PDF)

Neoadjuvant therapy for surgically staged IIIA N2 non-small cell lung cancer (NSCLC)

Lung cancer (Amsterdam, Netherlands), 1997-05, Vol.17 (1), p.147-161

1997

Volltextzugriff (PDF)

Analysis of Long-term Survivors With Small-Cell Lung Cancer

Chest, 1993-04, Vol.103 (4), p.440S-444S

Skarin, Arthur T.

1993

Volltextzugriff (PDF)

Intermediate lymphocytic lymphoma: clinical and pathologic features of a recently characterized subtype of non-Hodgkin's lymphoma

Journal of clinical oncology, 1993-04, Vol.11 (4), p.802-811

1993

Volltextzugriff (PDF)

Haptoglobin α-subunit and hepatocyte growth factor can potentially serve as serum tumor biomarkers in Small cell lung cancer

Anticancer research, 2004-03, Vol.24 (2C), p.1031-1038

2004

Volltextzugriff (PDF)

Intensive Combined Modality Therapy for Limited-Stage Small-Cell Lung Cancer

JNCI : Journal of the National Cancer Institute, 1993-04, Vol.85 (7), p.559-566

1993

Volltextzugriff (PDF)

Identification of major prognostic subgroups of patients with large-cell lymphoma treated with m-BACOD or M-BACOD

Annals of internal medicine, 1986-06, Vol.104 (6), p.757

1986

Volltextzugriff (PDF)

Multimodality treatment of stage IIIA non-small-cell lung carcinoma: a critical review of the literature and strategies for future research

Journal of clinical oncology, 1992-05, Vol.10 (5), p.829-838

1992

Volltextzugriff (PDF)

Improved prognosis of diffuse histiocytic and undifferentiated lymphoma by use of high dose methotrexate alternating with standard agents (M-BACOD)

Journal of clinical oncology, 1983-02, Vol.1 (2), p.91-98

1983

Volltextzugriff (PDF)

Cancer-associated retinopathy in a patient with non-small-cell lung carcinoma

Lung cancer (Amsterdam, Netherlands), 1998-11, Vol.22 (2), p.149-152

1998

Volltextzugriff (PDF)

Analysis of neuroendocrine markers, HER2 and CEA before and after chemotherapy in patients with stage IIIA non-small cell lung cancer: A Cancer and Leukemia Group B study

Lung cancer (Amsterdam, Netherlands), 1998-09, Vol.21 (3), p.203-211

1998

Volltextzugriff (PDF)

Multimodality therapy of patients with stage IIIA, N2 non-small-cell lung cancer. Impact of preoperative chemotherapy on resectability and downstaging

The Journal of thoracic and cardiovascular surgery, 1993-10, Vol.106 (4), p.696-702

1993

Volltextzugriff (PDF)

The m-BACOD combination chemotherapy regimen in large-cell lymphoma: analysis of the completed trial and comparison with the M-BACOD regimen

Journal of clinical oncology, 1990-01, Vol.8 (1), p.84-93

1990

Volltextzugriff (PDF)

Use of Tumor Markers in Lung Cancer

Hematology/oncology clinics of North America, 1994-06, Vol.8 (3), p.507-532

1994

Volltextzugriff (PDF)

Detection of bone marrow metastasis in small-cell lung cancer by monoclonal antibody

Journal of clinical oncology, 1985-04, Vol.3 (4), p.455-461

1985

Volltextzugriff (PDF)

Hypertrophic osteoarthropathy

Journal of clinical oncology, 1997-07, Vol.15 (7), p.2759-2760

1997

Volltextzugriff (PDF)

Gynecomastia in a patient with lung cancer

Journal of clinical oncology, 1999-06, Vol.17 (6), p.1956-1957

1999

Volltextzugriff (PDF)

Lung cancer in patients under age 40

Lung cancer (Amsterdam, Netherlands), 2001-06, Vol.32 (3), p.255-264

2001

Volltextzugriff (PDF)

CHEMOTHERAPY FOR ADVANCED NON–SMALL CELL LUNG CANCER

Hematology/oncology clinics of North America, 1997-06, Vol.11 (3), p.473-517

1997

Volltextzugriff (PDF)

1 – 25 von 489

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(356)
Mit Volltextzugriff
(341)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(271)
Life Sciences & Biomedicine
(229)
Humans
(206)
Female
(138)
Male
(116)
Oncology
(110)
Adult
(89)
Middle Aged
(89)
Biological And Medical Sciences
(83)
Aged
(80)
Medical Sciences
(77)
Animals
(40)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(39)
Lung Neoplasms - Drug Therapy
(39)
Pharmacology. Drug Treatments
(35)
Antineoplastic Agents
(30)
Ecology
(30)
Lung Neoplasms - Pathology
(30)
Technology
(29)
Chemotherapy
(27)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(3)
... seit 90 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

Molecular abnormalities in lung cancer

Use of cytokeratins 7 and 20 in determining the origin of metastatic carcinoma of unknown primary, with special emphasis on lung cancer

Randomized trial of chemotherapy and radiation therapy with or without warfarin for limited-stage small-cell lung cancer: a Cancer and Leukemia Group B study

Role of serum tumor markers CA 125 and CEA in non-small cell lung cancer

Non-Hodgkin's lymphomas: current classification and management

Molecular and pathologic markers in stage I non-small-cell carcinoma of the lung

Dose-Intensive Therapy for Limited-Stage Small-Cell Lung Cancer: Long-Term Outcome

Neoadjuvant therapy for surgically staged IIIA N2 non-small cell lung cancer (NSCLC)

Analysis of Long-term Survivors With Small-Cell Lung Cancer

Intermediate lymphocytic lymphoma: clinical and pathologic features of a recently characterized subtype of non-Hodgkin's lymphoma

Haptoglobin α-subunit and hepatocyte growth factor can potentially serve as serum tumor biomarkers in Small cell lung cancer

Intensive Combined Modality Therapy for Limited-Stage Small-Cell Lung Cancer

Identification of major prognostic subgroups of patients with large-cell lymphoma treated with m-BACOD or M-BACOD

Multimodality treatment of stage IIIA non-small-cell lung carcinoma: a critical review of the literature and strategies for future research

Improved prognosis of diffuse histiocytic and undifferentiated lymphoma by use of high dose methotrexate alternating with standard agents (M-BACOD)

Cancer-associated retinopathy in a patient with non-small-cell lung carcinoma

Analysis of neuroendocrine markers, HER2 and CEA before and after chemotherapy in patients with stage IIIA non-small cell lung cancer: A Cancer and Leukemia Group B study

Multimodality therapy of patients with stage IIIA, N2 non-small-cell lung cancer. Impact of preoperative chemotherapy on resectability and downstaging

The m-BACOD combination chemotherapy regimen in large-cell lymphoma: analysis of the completed trial and comparison with the M-BACOD regimen

Use of Tumor Markers in Lung Cancer

Detection of bone marrow metastasis in small-cell lung cancer by monoclonal antibody

Hypertrophic osteoarthropathy

Gynecomastia in a patient with lung cancer

Lung cancer in patients under age 40

CHEMOTHERAPY FOR ADVANCED NON–SMALL CELL LUNG CANCER

Suchergebnisse filtern